Led · Series B · Oct 2024

Medtrace Pharma A/S operates a platform for the production, infusion and analysis of 15O-water used in medical imaging. The technology is applied to myocardial perfusion imaging and other indications that require perfusion data, including heart scans. The company raised $30 million in a Series B to scale its platform and operations. Lead investors in the round are Swisscanto Invest, ATP and the Bankinvest group. CEO and co‑founder Martin Stenfeldt said the funding will enable ramping European and U.S. expansion plans in myocardial perfusion imaging and other perfusion applications. The capital is intended to support production, infusion and analytical capabilities needed to deploy 15O-water imaging more broadly across clinical settings.

Participated · Equity · Jan 2011

Sulfurcell develops, manufactures and sells CIGS/CIGSe thin‑film photovoltaic modules and building-integrated PV solutions for BIPV, solar construction and commercial rooftops. The company has commercialized at scale since shipping its first modules in 2005 and is ramping up a 35 MW production facility. Sulfurcell reports manufacturing full‑scale thin‑film modules at 12.6% efficiency and is targeting 14% efficiency within 12–18 months through ongoing R&D. The company employs about 250 people and has developed an automated industrial manufacturing process for its second‑generation thin‑film technology. Sulfurcell was founded in 2001 as a spin‑off from the Helmholtz Centre for Materials and Energy and has received multiple rounds of growth financing to support production and R&D, including a prior €85m round used to build a Berlin production facility. The recent equity raise will fund expansion and market introduction of its second‑generation CIGSe PV technology.

Participated · Series A · May 2010

O-Flexx Technologies GmbH is a Duisburg, Germany-based developer and manufacturer of thermo-electric elements that enable the economic use of both low- and high-grade waste heat across a broad variety of applications. Its core products are high-efficient, low-cost thermo-electric elements intended for waste-heat recovery. The company completed a €6.7m extended Series A financing. The investment was made by SET Venture Partners, which joined existing investors ATMOS, BankInvest, Emerald Technology Ventures, Partech International, SAM GmbH and Schneider Electric Ventures. The new funds will enable O-Flexx to run a manufacturing plant and to roll out its thermo-electric elements. As part of the financing, Rene Savelsberg, CEO of SET Venture Partners, joined the company's board of directors.

Participated · Equity · Sep 2009

Nujira Ltd develops Envelope Tracking (ET) technology and Coolteq ET chips aimed at improving performance and efficiency in 4G smartphones and other wireless devices. The company closed a $20M funding round to provide working capital for a production ramp of its Coolteq chips and to fund continued development of its long-term product roadmap. To support product development and US customers, Nujira will open a new design centre in Santa Clara, California to develop next-generation ET ICs and provide local applications and operations support. Founded in 2002 and led by CEO Tim Haynes, the company employs over 60 people and is engaged with all major smartphone chipset vendors. Nujira expects its Coolteq.L ET chips to be designed into 4G smartphones in 2014. Nujira develops Envelope Tracking (ET) technology and its Coolteq® power modulator solutions to enable power-efficient 3G/4G wireless transmitters for cellular terminals, infrastructure and digital broadcast systems. The company is led by CEO Tim Haynes and has design centres in Cambridge and Edinburgh. Nujira says it is engaged with 16 major smartphone chipset suppliers to embed its ET technology into their reference platforms and expects its Coolteq.L technology to be designed into 4G smartphones in 2013. The company intends to use new capital to continue developing its technology and to reinforce the value of its ET patent portfolio. Nujira has previously been backed by NES Partners, Environmental Technologies Fund, Amadeus Capital Partners and Climate Change Capital Private Equity. It recently raised additional funding to support these product and IP objectives. Nujira develops Coolteq wideband Envelope Tracking and High Accuracy Tracking (HAT™) modulator technology to dynamically control RF power amplifiers and cut transmitter waste heat. The company says its technology reduces power consumption in smartphone transmitters by 30–50% and is shipping silicon. Nujira has built an extensive patent portfolio covering Envelope Tracking and efficient wideband PA transmission systems. Management aims to install Coolteq into 800 million 3G and 4G devices by 2016 and to make the technology the power-optimisation choice for smartphones and other data-oriented devices. The new funding will be used to expand the handset engineering team to support product development and engagements with leading global handset vendors. Nujira is headquartered in Cambourne, Cambridge, United Kingdom. Nujira, based in Cambridge, UK, develops technology to dramatically improve the energy efficiency of cellular network base stations and digital broadcast transmitters by reducing waste energy in the RF Power Amplifier circuit. The company commercialises its Coolteq products. Proceeds from the funding will be used to accelerate development of its handset technology, support expansion into a new market, and support general commercial development in the Cellular Infrastructure and TV Broadcast sectors. CEO Tim Haynes said the new investment provides the opportunity to continue commercialisation of Coolteq products and to promote the technology into new markets. The article cites existing investor support from Bank Invest, 3i, Amadeus and Mitsubishi UFJ Capital alongside the new investor.